Given that melanoma is a highly metastatic cancer, these results suggest that melanoma-secreted ISG15 may have contributed to the recent findings of Cunningham et al. [16] regarding the generation of immunosuppressive DCs in melanoma, perhaps through the ISG15-mediated induction of type I IFN signaling pathways. The gene discussed is ISG15; the disease is cancer.